
Keiretsu Capital
Description
Keiretsu Capital operates as the exclusive worldwide fund manager for Keiretsu Forum, which is recognized as the world's largest angel investor network. Based in Seattle, Washington, Keiretsu Capital leverages this extensive network to identify and invest in promising early-stage companies. Its primary function is to provide accredited investors with access to proprietary deal flow, pooling capital to facilitate investments that might otherwise be inaccessible to individual angels. This unique structure allows the firm to combine the agility of angel investing with the strategic depth of a venture fund.
The firm primarily targets early-stage companies across a diverse range of high-growth sectors, including technology, life sciences, and consumer products. Keiretsu Capital manages several distinct funds, such as Keiretsu Capital Fund I, Fund II, and the Opportunities Fund, each designed to deploy capital strategically into its target companies. Typical first checks from Keiretsu Capital's funds range from $250,000 to $1,000,000, participating in broader funding rounds that can extend up to $5 million. This approach allows them to support companies through critical early development phases.
Keiretsu Capital's investment strategy is deeply integrated with the Keiretsu Forum's global reach, which boasts over 3,000 members across 50+ chapters worldwide. This vast network contributes significantly to deal sourcing and due diligence processes. Since its inception, the Keiretsu Forum, through its various investment vehicles including Keiretsu Capital, has facilitated over $1 billion in funding for early-stage companies. The firm's diversified portfolio currently includes investments in over 200 companies, demonstrating its active role in the startup ecosystem. Keiretsu Capital aims to provide its limited partners with a diversified portfolio of high-potential ventures, benefiting from the collective expertise and extensive deal flow generated by the Keiretsu Forum.
Investor Profile
Keiretsu Capital has backed more than 278 startups, with 1 new investments in the last 12 months alone. The firm has led 4 rounds, about 1% of its total and boasts 18 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Convertible Note, Seed rounds (top funding stages).
- Majority of deals are located in United States, Canada, United Kingdom.
- Strong thematic focus on Health Care, Biotechnology, Medical Device.
- Typical check size: $250K – $1M.
Stage Focus
- Series A (27%)
- Convertible Note (23%)
- Seed (20%)
- Series Unknown (13%)
- Series B (10%)
- Series C (2%)
- Post Ipo Equity (1%)
- Angel (1%)
- Private Equity (1%)
- Grant (1%)
Country Focus
- United States (92%)
- Canada (5%)
- United Kingdom (1%)
- Israel (1%)
- India (1%)
Industry Focus
- Health Care
- Biotechnology
- Medical Device
- Medical
- Software
- Therapeutics
- Information Technology
- Saas
- Manufacturing
- Health Diagnostics
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.